Prerecorded Webinar: A Review of Benign Prostatic Hyperplasia

Pharmacist CEU
Contact Hours: 1.0 (0.1 CEUs)

Course Summary

Within the realm of male health conditions, benign prostatic hyperplasia (BPH) is a disorder with major public health consequences. Patients with BPH require a patient-centered, holistic approach to care that involves improving symptoms and quality of life, preventing disease progression, and minimizing medication side effects. All healthcare providers can play an important role in identifying patients requiring BPH treatment, recommending referrals, and helping the care team with BPH medication management. Further, pharmacists can provide crucial counseling on the appropriate use of BPH medications and help patients to mitigate side effects and avoid harmful drug interactions. This course will review the etiology and pathophysiology of BPH and describe available treatment options in detail, including appropriate administration, mechanisms of action, side effects, and contraindications. The role of the pharmacist in caring for patients with BPH will be discussed.

Course Objectives

Describe the underlying causes of benign prostatic hyperplasia (BHP)

Compare and contrast treatment options for BPH

Recall indications, contraindications, side effect profiles, and monitoring parameters for BPH treatments

I. Introduction

II. BPH: An Overview

1. Epidemiology
2. Pathophysiology
3. Etiology
4. Diagnosis
5. Medication-Related Causes of BPH

III. Management of BPH

1. Watchful Waiting
2. Pharmacologic Treatment
3. Alpha-1 Adrenergic Antagonists
4. Alpha Blocker Efficacy
5. 5-alpha Reductase Inhibitors
6. Muscarinic Receptor Antagonists (MRAs)
7. Phosphodiesterase-5 Inhibitor (PDE-5)
8. Mirabegron
9. Combination Therapy
10. Nutraceuticals
11. Surgical Interventions

IV. The Role of the Clinician

V. Summary

How to Earn Credit:
To earn credit for this course, participants must:
  1. Read the course objectives and faculty planner disclosure
  2. Read the course material
  3. Complete the post-test with a minimum score of 70% and complete the course evaluation form.
  4. Results are automatically submitted to CPE Monitor

Faculty Planner Disclosure

The following individuals were involved in the development of this activity: L. Austin Fredrickson, MD, FACP, and Susan DePasquale, MSN, PMHNP-BC. There are no financial relationships relevant to this activity to report or disclose by any of the individuals involved in the development of this activity.

Unlabeled Use Disclosures

The information provided in this course is general in nature and it is solely designed to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant’s professional practice, including but not limited to patient assessment, diagnosis, treatment and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals, including pharmacists and pharmacy technicians, must consult with their employer, healthcare facility, hospital, or other organization, for guidelines, protocols, and procedures they are to follow. The information provided in this course does not replace those guidelines, protocols, and procedures but is for academic purposes only, and this course’s limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses are constantly changing, and any person taking this course understands that such person must make an independent review of medication information prior to any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of LLC. LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course, or course material.

Computer Hardware/Software Requirements

Please ensure the device you plan to use meets these requirements and specifications:

  • Operating System: Windows 7,8,10, or 11 /Mac OS X 10.9 or later/iOS/Android
  • Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
  • A connection to the internet
  • For Live Webinars or Conferences: GoToWebinar application for iOS, Android, Mac, or PC. You cannot 'call into' a live conference.

  • Target Audience: Pharmacist
  • Contact Hours: 1.0 (0.1 CEUs)
  • Activity Release Date: 3/18/2023
  • Activity Expiration Date: 3/18/2026
  • Activity Type: Knowledge
  • UAN: 0669-0000-23-042-H01-P
  • Topic: Disease State Management/Drug Therapy
  • CeBroker Number: 20-1003262


L. Austin Fredrickson, MD, FACP



The logo for the Accreditation Council for Pharmacy Education (ACPE)., LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

‹‹ Back to Course List